Azitra

Branford, United States

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

$31.0M raised

Mar 2026

Post Ipo Equity

Alternative Medicine Biotechnology Consumer Goods Health Care

Top Investors

National Science FoundationConnecticut InnovationsKdT VenturesNational Institutes of HealthU.S. Department of Defense

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Azitra

How much funding has Azitra raised?

Azitra has raised $31.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.

Who are Azitra's investors?

Azitra's investors include National Science Foundation, Connecticut Innovations, KdT Ventures, National Institutes of Health, U.S. Department of Defense.

Where is Azitra headquartered?

Azitra is headquartered in Branford, United States.

What does Azitra do?

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

What stage is Azitra at?

Azitra is at the Post Ipo Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 19, 2026.

MLA

"Azitra — Funding & Investors." VCBacked, March 19, 2026, https://www.vcbacked.co/company/azitra. Accessed June 3, 2026.

APA

VCBacked. (2026). Azitra — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/azitra

Wikipedia (cite web)

{{cite web |title=Azitra — Funding & Investors |url=https://www.vcbacked.co/company/azitra |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 19, 2026.

Similar Companies in Alternative Medicine